当前位置:首页 - 行情中心 - 睿智医药(300149) - 财务分析

睿智医药

(300149)

  

流通市值:55.57亿  总市值:58.31亿
流通股本:4.75亿   总股本:4.98亿

睿智医药(300149)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.25亿元,每股收益0.05元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益126228.04万元,未分配利润-65518.96万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产198058.69万元,负债71830.65万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入533,797,976.84261,261,312.24970,204,758.8718,525,731.65
营业总成本513,553,112.14260,328,377.291,031,638,143.67774,216,447.7
其他经营收益
营业利润31,671,672.699,366,855.16-216,837,181.52-66,557,761.02
利润总额32,110,947.089,323,669.29-231,643,863-67,038,704.04
净利润25,345,366.236,623,398.35-226,512,315.17-61,782,349.49
每股收益
其他综合收益-374,978.77-272,754.983,689,524.72-9,433,940.61
综合收益总额24,970,387.466,350,643.37-222,822,790.45-71,216,290.1
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计680,417,089.77645,941,574.54644,069,184.3623,951,592
非流动资产:
非流动资产合计1,300,169,768.431,341,121,583.271,351,738,784.961,532,696,936
资产总计1,980,586,858.21,987,063,157.811,995,807,969.262,156,648,528
流动负债:
流动负债合计343,418,505.78333,746,540.5346,697,976.55347,226,879.58
非流动负债:
非流动负债合计374,888,002.33408,903,156.39411,047,175.16419,752,330.52
负债合计718,306,508.11742,649,696.89757,745,151.71766,979,210.1
所有者权益(或股东权益):
归属于母公司股东权益合计1,238,115,581.31,220,230,623.221,213,861,296.551,365,545,650.89
股东权益合计1,262,280,350.091,244,413,460.921,238,062,817.551,389,669,317.9
负债和股东权益合计1,980,586,858.21,987,063,157.811,995,807,969.262,156,648,528
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计583,016,858.73257,944,775.861,073,629,719.51788,197,815.19
经营活动现金流出小计517,681,774.34247,886,029.1905,422,428.43675,652,696.34
经营活动产生的现金流量净额65,335,084.3910,058,746.76168,207,291.08112,545,118.85
投资活动产生的现金流量:
投资活动现金流入小计61,612,910.81632,530.327,221,215.115,806,006.03
投资活动现金流出小计89,818,772.9511,982,154.4274,889,662.0764,233,346.97
投资活动产生的现金流量净额-28,205,862.14-11,349,624.1-67,668,446.96-58,427,340.94
筹资活动产生的现金流量:
筹资活动现金流入小计36,300,000-58,450,00028,450,000
筹资活动现金流出小计86,109,221.3419,430,180.29144,886,348.34109,664,255.98
筹资活动产生的现金流量净额-49,809,221.34-19,430,180.29-86,436,348.34-81,214,255.98
汇率变动对现金及现金等价物的影响633,349.4314,695.077,117,000.81-1,598,568.52
现金及现金等价物净增加额-12,046,649.69-20,406,362.5621,219,496.59-28,695,046.59
期末现金及现金等价物余额351,402,222.11343,000,036.81363,448,871.8313,534,328.62
补充资料:
现金及现金等价物的净增加额-12,046,649.69-21,219,496.59-
TOP↑